Elif-Damla Arisan

24PUBLICATIONS
46CO-AUTHORS
Predictive and prognostic markersMechanobiologyAgricultural molecular engineering of nucleic acids and proteinsCancer cell biologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Feb 16, 2026
Chemopreventive Effects of Lycopene in miR-21 Knockout and Wild-Type Pancreatic Cancer Cells.

Basak Dalbayrak, Burcu Taluğ Taştan, Tuğçe Temel

|Nov 04, 2025
Boron-Enhanced Mitochondrial Repair: DeepA-I Tissue Regeneration.

Beyza Yılmaz, Basak Dalbayrak, Mustafa Kucukali

|May 27, 2025
Biocompatible PLA/spirulina microparticles via electrospraying for targeted drug delivery in HUVEC and HaCaT cell lines.

Basak Dalbayrak, Isil Aksan Kurnaz, Sumeyye Cesur

|Apr 26, 2025
Proteomic and In Silico Analyses Highlight Complement System's Role in Bladder Cancer Immune Regulation.

Tuğcan Korak, İbrahim Halil Baloğlu, Murat Kasap

|Aug 03, 2023
The comparison of differentially expressed microRNAs in Bag-1 deficient and wild type MCF-7 breast cancer cells by small RNA sequencing.

Pelin Özfiliz Kilbaş, Gizem Alkurt, Pinar Obakan Yerlikaya

|Aug 02, 2023
Gemcitabine in combination with epibrassinolide enhanced the apoptotic response in an ER stress-dependent manner and reduced the epithelial-mesenchymal transition in pancreatic cancer cells.

Pınar Obakan Yerlikaya, Leila Mehdizadehtapeh, Özge Rencüzoğullari

Pageof 4